Hutubessy RCW - Search Results

1

A Scoping Review of Investment Cases for Vaccines and Immunization Programs.

Sim SY, Jit M, Constenla D, Peters DH, Hutubessy RCW. Sim SY, et al. Among authors: hutubessy rcw. Value Health. 2019 Aug;22(8):942-952. doi: 10.1016/j.jval.2019.04.002. Epub 2019 Jun 10. Value Health. 2019. PMID: 31426936 Free article.

2

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM. Wolfson LJ, et al. Bull World Health Organ. 2008 Jan;86(1):27-39. doi: 10.2471/blt.07.045096. Bull World Health Organ. 2008. PMID: 18235887 Free PMC article.

3

WHO Guide for standardisation of economic evaluations of immunization programmes.

Walker DG, Hutubessy R, Beutels P. Walker DG, et al. Vaccine. 2010 Mar 8;28(11):2356-9. doi: 10.1016/j.vaccine.2009.06.035. Epub 2009 Jun 28. Vaccine. 2010. PMID: 19567247 Review.

4

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R. Jit M, et al. BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.

5

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal.

Hutubessy R, Henao AM, Namgyal P, Moorthy V, Hombach J. Hutubessy R, et al. BMC Med. 2011 May 12;9:55. doi: 10.1186/1741-7015-9-55. BMC Med. 2011. PMID: 21569407 Free PMC article.

6

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HA, Hutubessy RC. Postma MJ, et al. BMC Med. 2011 Jul 8;9:84. doi: 10.1186/1741-7015-9-84. BMC Med. 2011. PMID: 21740545 Free PMC article. Review.

7

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Deogaonkar R, et al. BMC Public Health. 2012 Oct 16;12:878. doi: 10.1186/1471-2458-12-878. BMC Public Health. 2012. PMID: 23072714 Free PMC article. Review.

8

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N. Hutubessy R, et al. BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136. BMC Med. 2012. PMID: 23146319 Free PMC article.

9

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Jit M, et al. BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23. BMC Med. 2013. PMID: 23363734 Free PMC article.

10

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR. Ott JJ, et al. Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Hum Vaccin Immunother. 2013. PMID: 23732900 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters